JRSS — JRSIS HEALTH CARE Income Statement
0.000.00%
- $3.16m
- $4.46m
- $3.46m
- 39
- 69
- 13
- 35
Annual income statement for JRSIS HEALTH CARE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.5 | 35.7 | 0 | 0.089 | 3.46 |
Cost of Revenue | |||||
Gross Profit | 23.6 | 28.9 | — | — | 0.483 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 26.8 | 30.1 | 0.104 | 0.415 | 3.65 |
Operating Profit | 4.67 | 5.59 | -0.104 | -0.326 | -0.189 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.93 | 5.2 | -0.104 | -0.328 | -0.086 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.27 | 3.83 | -0.104 | -0.328 | -0.095 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.888 | 2.68 | 3.19 | -33.7 | -0.081 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.888 | 2.68 | 3.19 | -33.7 | -0.081 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.529 | 1.47 | -0.056 | -0.073 | -0.001 |